KRISTEN WRIGHT: Open Payments
NPI 1841755014 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 17 payments from 6 companies in 2025. Trend: 2023 $613 · 2024 $1,276 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $684 |
| Merck Sharp & Dohme LLC | 1 | $104 |
| Stemline Therapeutics Inc. | 1 | $101 |
| ARRAY BIOPHARMA INC | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: IMFINZI, DATROWAY, KEYTRUDA, Orserdu, Enhertu, BRAFTOVI, LORBRENA, LEQVIO.
Industry payments across NJ — which companies pay providers there.
